Novel accelerator target technology for improved production of medical isotopes:
Historically, research within TRIUMF’s Life Science division has focused on the world’s more common PET isotopes: 11C, 13N and 18F. However, through new target development in recent years, this list has been dramatically expanded to include new isotopes through new target development: 68Ga, 44Sc, 86Y, 89Zr, 192Ir, 52Mn, 61,64Cu, 99mTc and 119Sb. One of these new target systems is the so-called solution target, modelled after the remotely-controlled 18F production process currently used in medical cyclotrons. In lieu of a traditional solid target station, this technique allows for the irradiation of solutions (for example: nitrate solutions of metals of interest) in a cost-efficient, simple, and safe manner.